Skip to content
healthcare.dev

FINACEA FOAM

NDC 50222-303, azelaic acid, aerosol, foam, from LEO Pharma Inc..

Product NDC
50222-303
Status
Listed
Labeler
LEO Pharma Inc.
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50222-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELAIC ACID.15 g/g

Pharmacologic classes

Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]

Package NDCNDC-11Package
50222-303-50502220303501 CAN in 1 CARTON (50222-303-50) / 50 g in 1 CAN
50222-303-91502220303911 CAN in 1 CARTON (50222-303-91) / 15 g in 1 CAN

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9fabd24e-4c3b-49a0-aa5f-c8d75ae67572
  • NADAC price for package 50222030350

    GET /v1/drugs/nadac/50222030350

Use it

Look up 50222-303 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50222-303 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50222-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.